Welcome to the latest edition of Vision Voice.
Welcome to the latest edition of Vision Voice.
MDFA has received a positive response from the people participating in our new Eye Connect support service.
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
Sharing stories about people who are going through similar health experiences can help others manage their own condition. So, when we listened to a very personal and uplifting interview with Shane Somerville from the InSight Systems podcast, we knew we wanted to share it.
MDFA is pleased to announce that NSW government’s former Minister for Health and Minister for Medical research, the Hon. Jillian Skinner AM, has joined as our newest Ambassador.
Welcome to the latest edition of Vision Voice.
New findings reveal that consuming more than 12g of alcohol per day (less than one large glass of wine or large beer) is linked to a higher risk of developing irreversible vision loss; new nutrition guidelines released to help protect Australians’ eyesight.
Find out how the Grant Family Fund is helping Dr Xavier Hadoux use cutting-edge technology to detect the early signs of macular disease.
A/Prof Gerald Liew’s second MDFA Research Grant is allowing him to investigate a potential sight-saving supplement to improve dysfunctional mitochondria and prevent age-related macular degeneration (AMD).
Our final Vision Voice for the year celebrates two remarkable centenarian members of our community who are vigilant in maintaining their vision with sight-saving eye injections.
The centenarian, whose bookshelves and cupboards are crammed with biographies, literary classics and the odd Agatha Christie mystery, regards her regular eye injections as a lifeline.
2025 MDFA research grant awards presented at Admiralty House
Next-generation gene therapy for Stargardt Disease: Enhanced AAV-mediated ABCA4 delivery to restore vision
Macular vascular disease: software standardisation and data harmonisation to accelerate the development of new imaging biomarkers and therapies
Genotype-phenotype correlations in PRPH2-associated retinal dystrophy
Nocturnal hypoxia: An unrecognised risk factor for neovascular age-related macular degeneration
Towards a personalised approach to predicting and preventing progression of age-related macular degeneration
Exploring exosomal therapeutics delivery strategies for macular disease
Reducing the risk of end-stage complications of neovascular age-related macular degeneration: macular atrophy and subretinal fibrosis
Driving into the future: strategies to enhance independence for drivers with macular degeneration, including licensing options and the role of modern vehicle technology